002720.KS
Kukje Pharma Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 3,385.00
−0.88%Margins
Gross margin
53.5%
EBITDA margin
4.7%
EBIT margin
2.5%
Net margin
2.8%
FCF margin
1.3%
5.0%
Return on equity
2.7%
Return on assets
3.4%
Return on invested capital
1.00x
Asset turnover
KRW 6.7B
Cash from operations
KRW 743
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026